Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research reports from C.Z. Han and co-authors provide new insights into breast cancer
February 5th, 2009
"We evaluated the relationship among the leptin receptor (LEPR) gene Gln223Arg polymorphism, body mass index (BMI), waist and hip circumference ratio (WHR), dietary structure, lifestyle, and other biomarkers with breast cancer and determined whether they could be effective for the prevention and treatment of breast cancer. The Gln223Arg polymorphisms in the LEPR gene were investigated in blood deoxyribonucleic acid (DNA) available for 240 breast cancer cases and 500 controls," scientists in Taiyuan, People's Republic of China report. "Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism. Leptin, insulin were determined by...
Source: Women's Health Weekly (2009-02-05)
|
